Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Nektar Therapeutics
(NQ:
NKTR
)
10.95
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Nektar Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stimulus Measures May Slow This Year, Markets Plunge
June 19, 2013
Federal Reserve chairman Ben Bernanke indicated that economic stimulus measures may decrease later this year sending the stock price plunging to a sharply lower close with the Dow collapsing 206 points...
Read More
category
Market News
from
MarketMinute.com Market Updates
Bio-Wire Equity Surveillance – Closing Bell 6/19/2013
June 19, 2013
Wednesday, June 19th, 2013 DJIA: -1.35% ?15,112.19 S&P 500: -1.39% ? 1628.93 NASDAQ: -1.12% ?3443.20 NASDAQ Biotech: -2.08% ?1,805.07 NYSE Arca – Pharma Index: -1.55% ?424.87 Big pharma (Mkt Cap $10...
Read More
category
NKTR
,
REGN
,
QCOR
, and 3 more.
from
Bio-Wire.Com
Market Wrap for Wednesday, June 19: Stocks Plunge as Federal Reserve Discusses Pulling Back Stimulus
June 19, 2013
The U.S. stock market plunged in afternoon trading on Wednesday after Federal Reserve Chairman Ben Bernanke said that the central bank could begin tapering its quantitative easing program later this...
Read More
category
TTEK
,
Earnings
,
NKTR
, and 26 more.
from
Latest Articles from Benzinga.com
Unusual 11 Mid-Day Movers 06/19: (MBIS) (MNOV) (AVHI) Higher; (OSH) (VNDA) (ZN) Lower
June 19, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8431590 for the full story.
Read More
from
StreetInsider.com News Articles
Mid-Day Market Update: La-Z-Boy Drops On Q4 Results, Nektar Gains
June 19, 2013
Midway through trading Wednesday, the Dow traded down 0.05 percent to 15,309.86 while the NASDAQ declined 0.09 percent to 3,479.11. The S&P also fell, dropping 0.08 percent to 1,650.51. Top Headline...
Read More
category
TTEK
,
Earnings
,
NKTR
, and 17 more.
from
Latest Articles from Benzinga.com
Afternoon Market Gainers
June 19, 2013
Bluebird Bio (NASDAQ: BLUE ) traded up 49.55 percent to $25.41. Wednesday's IPO for the company was initially priced at $17. Nektar Therapeutics (NASDAQ: NKTR ) rose 9.99 percent to $10.79 after...
Read More
category
NKTR
,
Benzinga
,
Movers
, and 5 more.
from
Latest Articles from Benzinga.com
Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Proble
June 19, 2013
NKTR-181 rates similar to placebo on "drug liking" and "feeling high" scores at all doses studied and differentiates from the widely abused drug oxycodone with high statistical significance (p<0.0001)
Read More
from
PR Newswire
Short Interest Drops 20.3% For NKTR
June 13, 2013
The most recent short interest data has been released by the NASDAQ for the 05/31/2013 settlement date, which shows a 1,700,119 share decrease in total short interest for Nektar Therapeutics (NKTR), to...
Read More
category
Stocks
from
Market News Video
RSI Alert For Nektar Therapeutics (NKTR)
June 05, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Read More
category
Stocks
from
Market News Video
Bio-Wire Equity Surveillance – Closing Bell 6/3/2013
June 03, 2013
Monday, June 3rd, 2013 Overview The market saw a bullish reversal today, which presumably upset bears who believed that we would finally see a decent pullback on lackluster macroeconomic data. The...
Read More
category
INFI
,
TSRO
,
Bio/Wire
, and 5 more.
from
Bio-Wire.Com
Nektar (NKTR) to Present Positive Preclinical NKTR-214 Data at ASCO
June 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8384649 for the full story.
Read More
from
StreetInsider.com News Articles
Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
June 03, 2013
NKTR-214 Demonstrates Improved Efficacy and Better Tolerability in Aggressive and Resistant Preclinical Melanoma Model
Read More
from
PR Newswire
Nektar Announces Target-Specific Biomarkers Being Evaluated in Phase 3 BEACON Study of Etirinotecan Pegol
June 01, 2013
Nektar Therapeutics (NASDAQ: NKTR ) announced today that it presented a series of target-specific biomarkers that are being evaluated in the development of etirinotecan pegol for the treatment of...
Read More
category
Contracts
,
NKTR
,
Management
, and 4 more.
from
Latest Articles from Benzinga.com
Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical O
June 01, 2013
from
PR Newswire
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the Jefferies 2013 Global Healthcare Conference in New York City
May 30, 2013
from
PR Newswire
NKTR Crosses Below Key Moving Average Level
May 22, 2013
In trading on Wednesday, shares of Nektar Therapeutics (NKTR) crossed below their 200 day moving average of $9.06, changing hands as low as $9.05 per share. Nektar Therapeutics shares are currently...
Read More
category
Stocks
from
Market News Video
Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
May 21, 2013
from
Business Wire News Releases
Nektar Therapeutics Earnings Hindsight: Down 1.4% in Last 11 Days (NKTR)
May 20, 2013
from
Comtex SmarTrend® News Briefs
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
May 16, 2013
from
PR Newswire
Nektar Therapeutics Enters Oversold Territory (NKTR)
May 10, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Read More
category
Stocks
from
Market News Video
Nektar Therapeutics (NKTR) Misses Q1 EPS by 6c, Sales Rise
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8323859 for the full story.
Read More
from
StreetInsider.com News Articles
Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
May 09, 2013
from
PR Newswire
Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
May 02, 2013
from
PR Newswire
55.5% Return Seen to Date on SmarTrend Nektar Therapeutics Call (NKTR)
April 30, 2013
from
Comtex SmarTrend® News Briefs
Technical Stock Breakout Watch: Nektar Therapeutics (NKTR)
April 29, 2013
Bridgewater, MA -- (SBWIRE) -- 04/29/2013 -- Bridgewater, MA - The online StockConsultant latest screen has found a biotech company that improves the benefits of drugs for patients Nektar Therapeutics...
Read More
from
SBWire - Latest Press Releases
Uptrend Call Working As Nektar Therapeutics Stock Rises 53.6% (NKTR)
April 22, 2013
from
Comtex SmarTrend® News Briefs
Traders Recap: Southwestern Energy, Nektar Therapeutics, PerkinElmer, VIVUS
April 22, 2013
Dallas, TX -- (SBWIRE) -- 04/22/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Investors Alert: Agnico-Eagle Mines Limited, Bill Barrett Corporation, Nektar Therapeutics, Union Pacific Corporation
April 19, 2013
Lakeway, NY -- (SBWIRE) -- 04/19/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on...
Read More
from
SBWire - Latest Press Releases
Stocks To Watch For April 19, 2013
April 18, 2013
( click to enlarge ) Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) had some nice gains today hitting a high of $4.73 ! Less than a month ago, this stock was trading at over $7 !! That’s a strong drop in...
Read More
category
NKTR
,
AEGR
,
TSLA
, and 6 more.
from
DailyMarkets.com
Stocks to Watch for April 19, 2013
April 18, 2013
category
RMBS
,
NKTR
,
AEGR
, and 3 more.
from
AC Investor Blog
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here